November 04, 2021
1 min watch
Save
VIDEO: Presbyopia drop improves intermediate visual acuity
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
BOSTON – Vuity, the first eye drop approved for treating presbyopia, showed significant improvement in acuity at intermediate distance at all hours tested through a 10-hour day, according to Chris Lievens, OD, MS, FNAP, FAAO.
The pilocarpine HCl ophthalmic solution 1.25% drop from Allergan, an Abbvie company, provides “a new-found way for patients to demonstrate acuity improvement at the distance at which we operate much of our working day,” Lievens said here at the American Academy of Optometry annual meeting. “This is truly exciting for a drug that was very well tolerated, with very few adverse events.”
Published by:
Sources/Disclosures
Collapse
Disclosures:
Lievens reports consulting for Allergan.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.